Mena Taalab, MBA, PMP®’s Post

Germany's Pioneering DIGA Act Spurs Digital Health Innovation, With Limits While the RCTs required to meet DiGA’s standards are not as onerous as traditional pharmaceutical pivotal trials, they are still time-consuming, and the statue allows manufacturers to get an extendable one-year listing based on preliminary evidence, which enables them to generate revenue while they complete the more rigorous studies required for a permanent listing (see Figure 1 below). Germany’s high-profile DiGA legislation has successfully encouraged digital therapeutics innovation, according to two new studies, although critics say it still leaves room for improvement. The US company Enovis, which embraces digital therapeutics as a promising business, and its German start-up partner Orthopy Health GmbH are testing the DiGA waters in what Enovis considers to be an important ex-US market opportunity: https://bit.ly/4eWlwj6 #digitaltherapeutics #digitalhealth #medtechinnovation #digitalhealthinnovation #Germany #medtech

🌟CALLING ALL PHARMACEUTICAL PROFESSIONALS! Join us at the WOCIP Cluster Meetings, where collaboration sparks innovation! See the exciting topics covered in all four targeted business meetings below! Stay tuned as we unveil the unique topics for each day! Join forces with peers in your role across the industry to tackle barriers to health equity together! 🌎 REGISTER BY APRIL 12th AND GET 50% OFF. Use the link and code in the comments. #WOCIP #HealthEquity #PharmaIndustry

🌟"Redefining Value" in the Pharma Industry: Excited to have been part of the 𝟭𝘀𝘁 𝗦𝗙𝗘𝗘 𝗦𝘂𝗺𝗺𝗶𝘁🌟 Our Partner, Angelos Benos, Pharma & Healthcare Industry Lead at PwC Greece, took the stage yesterday at the 1st SFEE Summit, during an intriguing panel on “𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀 & 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗥&𝗗”💡Angelos contributed valuable insights and added depth to a discussion concerning investments of the Pharmaceutical sector in R&D and in particular Clinical Trials. Clinical trials represent a very significant Foreign Direct Investment pot that our country unfortunately has historically failed to claim its fair share and Angelos put forward certain policy initiatives that can help boost competitiveness and attract R&D investments by the Big-Pharma. #PwCGreece #SFEESummit2024 #HealthcareInnovation #GreekPharma

Our CEO, Steffen Saltofte, participated as a panelist at the 65th GIRP - European Healthcare Distribution Association Annual Meeting & Conference in #Prague, the home of Zentiva's global headquarters, R&D, manufacturing site, and commercial operations. 🇨🇿 During the session titled "Rethinking Value in Healthcare: Transforming the Consumer Experience," Steffen shared his insights on the evolving pharmaceutical landscape, the impact of recent global events, and Zentiva's innovative strategies aimed at extending healthcare access to millions of people. Steffen emphasized the importance of European medicines production, stating, "Ensuring local pharmaceutical production is vital for safeguarding Europe's healthcare resilience. At #Zentiva, we are committed to delivering high-quality, affordable medicines that meet the needs of patients across Europe and beyond." This session explored how medicines are set to transform patient journeys, and reaffirmed our commitment to providing health and wellbeing for all generations. #HealthcareInnovation #GIRP2024 #Pharmaceuticals

🌟"Redefining Value" in the Pharma Industry: Excited to have been part of the 𝟭𝘀𝘁 𝗦𝗙𝗘𝗘 𝗦𝘂𝗺𝗺𝗶𝘁🌟 Our Partner, Angelos Benos, Pharma & Healthcare Industry Lead at PwC Greece, took the stage yesterday at the 1st SFEE Summit, during an intriguing panel on “𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀 & 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗥&𝗗”💡Angelos contributed valuable insights and added depth to a discussion concerning investments of the Pharmaceutical sector in R&D and in particular Clinical Trials. Clinical trials represent a very significant Foreign Direct Investment pot that our country unfortunately has historically failed to claim its fair share and Angelos put forward certain policy initiatives that can help boost competitiveness and attract R&D investments by the Big-Pharma. #PwCGreece #SFEESummit2024 #HealthcareInnovation #GreekPharma

Tomorrow I'll be speaking at the Digital Health Nexus conference on the 'Intersection between the Healthcare Provider & Pharmaceutical Industry In Digital Health Innovation'. I'll be discussing the potential for partnerships between NHS providers, digital innovators, and the pharmaceutical sector, while addressing common challenges and offering advice for achieving effective collaboration. Looking forward to connecting with attendees and feel free to share your thoughts on the topic! Nexus Conference ABHI Open Medical #digitalhealth #healthtech #healthcareinnovation #pharma #digitaltransformation #nhs

Spotlight on Pharma Innovators at Mobile in Clinical Trials 2024 -- As we gear up for this year's conference, we want to highlight the 15 confirmed pharmaceutical companies that are set to take the stage. These companies are not just participants; they are leaders in transforming clinical trials through mobile health technology, making research more efficient and patient-centric. Stay tuned for updates and learn more: https://lnkd.in/ggv8w76s #MobileClin2024 #MobileInClinicalTrials #PharmaInnovation #ClinicalResearch #HealthcareTechnology #PharmaLeaders #DigitalHealth #MobileHealth

Wataru Momose, Ph.D. (Dr. Momo), Ph.D., Director of Business Strategy, Otsuka Pharmaceutical Co., Ltd. Co Contributed an article "Insights into Healthcare Ecosystem" "In applying this mindset to disrupt the healthcare industry ecosystem, we can unite leaders from various industries, each with unique perspectives, while aligning with the shared goal of reducing medical costs and increasing healthy life expectancy."says Wataru Momose, Ph.D. The article will also be featured in the forthcoming special print edition on Pharma Consulting 2024. Read More: https://shorturl.at/hlpV1 #medicalcosts #healthcareindustry #pharmaceuticalcompanies #drugdiscovery

The IFPMA Decision-making Framework is a very helpful tool based on the IFPMA Ethos. 👍

 Excited to have participated in the esteemed "International Pharmaceutical Federation" webinar on "Working Together for the Future of Healthcare"! It was a fantastic opportunity to gain valuable insights into global trends shaping the healthcare landscape. Kudos to the speakers and organizers for such an enlightening session! Looking forward to applying these insights to enhance our collective efforts in advancing healthcare. #FIPWebinar #HealthcareTrends #Collaboration #PharmacyProfessionals